Stem cell therapy is a promising tool for refractory Angina: A meta-analysis of randomized controlled trials

Canadian Journal of Cardiology

Volumn 29, Issue 8, 2013, Pages 908-914

  Li, Na ^a   Yang, Yue Jin ^a   Zhang, Qian ^a   Jin, Chen ^a   Wang, Hong ^a   Qian, Hai Yan ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGINA PECTORIS; DEATH; EXERCISE TOLERANCE; HEART INFARCTION; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFRACTORY ANGINA; REVIEW; SAFETY; SENSITIVITY ANALYSIS; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW; THERAPY EFFECT;

ANGINA PECTORIS; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84881028010     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.12.003     Document Type: Review

References (48)

1. Mannheimer C., Camici P., Chester M.R., et al. The problem of chronic refractory angina: report from the ESC Joint Study Group on the Treatment of Refractory Angina. Eur Heart J 2002, 23:355-370.
2. Jolicoeur E.M., Ohman E.M., Temple R., et al. Clinical and research issues regarding chronic advanced coronary artery disease part II: trial design, outcomes, and regulatory issues. Am Heart J 2008, 155:435-444.
3. Jolicoeur E.M., Granger C.B., Henry T.D., et al. Clinical and research issues regarding chronic advanced coronary artery disease: part I: contemporary and emerging therapies. Am Heart J 2008, 155:418-434.
4. Shaw L.J., Bugiardini R., Merz C.N. Women and ischemic heart disease: evolving knowledge. JAm Coll Cardiol 2009, 54:1561-1575.
5. McGillion M., Arthur H.M., Cook A., et al. Management of patients with refractory angina: Canadian Cardiovascular Society/Canadian Pain Society joint guidelines. Can J Cardiol 2012, 28:S20-S41.
6. Brorsson B., Bernstein S.J., Brook R.H., Werko L. Quality of life of patients with chronic stable angina before and four years after coronary revascularisation compared with a normal population. Heart 2002, 87:140-145.
7. McGillion M., Watt-Watson J., LeFort S., Stevens B. Positive shifts in the perceived meaning of cardiac pain following a psychoeducation program for chronic stable angina. Can J Nurs Res 2007, 39:48-65.
8. Perin E.C., Geng Y.J., Willerson J.T. Adult stem cell therapy in perspective. Circulation 2003, 107:935-938.
9. Wollert K.C., Meyer G.P., Lotz J., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004, 364:141-148.
10. Schachinger V., Erbs S., Elsasser A., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. NEngl J Med 2006, 355:1210-1221.
11. Yousef M., Schannwell C.M., Kostering M., et al. The BALANCE study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. JAm Coll Cardiol 2009, 53:2262-2269.
12. Hirsch A., Nijveldt R., van der Vleuten P.A., et al. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. Eur Heart J 2011, 32:1736-1747.
13. Fuchs S., Satler L.F., Kornowski R., et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. JAm Coll Cardiol 2003, 41:1721-1724.
14. Tse H.F., Kwong Y.L., Chan J.K., et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003, 361:47-49.
15. Beeres S.L., Bax J.J., Dibbets P., et al. Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia. JNucl Med 2006, 47:574-580.
16. Fuchs S., Kornowski R., Weisz G., et al. Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease. Am J Cardiol 2006, 97:823-829.
17. Briguori C., Reimers B., Sarais C., et al. Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina. Am Heart J 2006, 151:674-680.
18. Mocini D., Staibano M., Mele L., et al. Autologous bone marrow mononuclear cell transplantation in patients undergoing coronary artery bypass grafting. Am Heart J 2006, 151:192-197.
19. Meluzin J., Mayer J., Groch L., et al. Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. Am Heart J 2006, 152:975.e9-975.e15.
20. Lipinski M.J., Biondi-Zoccai G.G., Abbate A., et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. JAm Coll Cardiol 2007, 50:1761-1767.
21. Clifford D.M., Fisher S.A., Brunskill S.J., et al. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev 2012, 2:CD006536.
22. Wen Y., Meng L., Ding Y., Ouyang J. Autologous transplantation of blood-derived stem/progenitor cells for ischaemic heart disease. Int J Clin Pract 2011, 65:858-865.
23. Higgins JPT, Altman DG, Sterne JAC, eds. Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version5.1.0 (updated March 2011). Cochrane Collaboration 2011. Available at: Accessed December 12,2012. http://www.cochrane-handbook.org.
24. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
25. Chan C.W., Kwong Y.L., Kwong R.Y., Lau C.P., Tse H.F. Improvement of myocardial perfusion reserve detected by cardiovascular magnetic resonance after direct endomyocardial implantation of autologous bone marrow cells in patients with severe coronary artery disease. JCardiovasc Magn Reson 2010, 12:6.
26. van Ramshorst J., Antoni M.L., Beeres S.L., et al. Intramyocardial bone marrow-derived mononuclear cell injection for chronic myocardial ischemia: the effect on diastolic function. Circ Cardiovasc Imaging 2011, 4:122-129.
27. Losordo D.W., Schatz R.A., White C.J., et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation 2007, 115:3165-3172.
28. Tse H.F., Thambar S., Kwong Y.L., et al. Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). Eur Heart J 2007, 28:2998-3005.
29. van Ramshorst J., Bax J.J., Beeres S.L., et al. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. JAMA 2009, 301:1997-2004.
30. Wang S., Cui J., Peng W., Lu M. Intracoronary autologous CD34+ stem cell therapy for intractable angina. Cardiology 2010, 117:140-147.
31. Losordo D.W., Henry T.D., Davidson C., et al. Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ Res 2011, 109:428-436.
32. Zhang S., Wang D., Estrov Z., et al. Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes invivo. Circulation 2004, 110:3803-3807.
33. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705.
34. Nygren J.M., Jovinge S., Breitbach M., et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004, 10:494-501.
35. Balsam L.B., Wagers A.J., Christensen J.L., et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004, 428:668-673.
36. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
37. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001, 7:430-436.
38. Kawamoto A., Iwasaki H., Kusano K., et al. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation 2006, 114:2163-2169.
39. Agata J., Chao L., Chao J. Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction. Hypertension 2002, 40:653-659.
40. Selvanayagam J.B., Jerosch-Herold M., Porto I., et al. Resting myocardial blood flow is impaired in hibernating myocardium: a magnetic resonance study of quantitative perfusion assessment. Circulation 2005, 112:3289-3296.
41. Iwasaki H., Kawamoto A., Ishikawa M., et al. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation 2006, 113:1311-1325.
42. Zhang S., Shpall E., Willerson J.T., Yeh E.T. Fusion of human hematopoietic progenitor cells and murine cardiomyocytes is mediated by alpha 4 beta 1 integrin/vascular cell adhesion molecule-1 interaction. Circ Res 2007, 100:693-702.
43. Boyle A.J., Whitbourn R., Schlicht S., et al. Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up. Int J Cardiol 2006, 109:21-27.
44. Kinnaird T., Stabile E., Burnett M.S., et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004, 109:1543-1549.
45. Kucia M., Zuba-Surma E., Wysoczynski M., et al. Physiological and pathological consequences of identification of very small embryonic like (VSEL) stem cells in adult bone marrow. JPhysiol Pharmacol 2006, 57(suppl 5):5-18.
46. Lee J.S., Bae G.Y., Lee M.O., Cha H.J. Oncogenic challenges in stem cells and the link to cancer initiation. Arch Pharm Res 2012, 35:235-244.
47. Leor J., Gerecht S., Cohen S., et al. Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart 2007, 93:1278-1284.
48. Nussbaum J., Minami E., Laflamme M.A., et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J 2007, 21:1345-1357.